Company Filing History:
Years Active: 2020-2025
Title: Innovations of Clayton Beard in Genetic Engineering
Introduction
Clayton Beard is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of genetic engineering. With a total of four patents to his name, Beard has made remarkable advancements in the development of genetically-modified cells for therapeutic applications.
Latest Patents
One of Beard's latest patents is focused on genetically-modified T cells that incorporate a modified intron in the T cell receptor alpha gene. This invention provides a genetically-modified T cell that includes a modified human T cell receptor alpha gene, which can disrupt the expression of the T cell receptor alpha subunit. The invention also outlines methods for producing these genetically-modified cells and their potential use in treating diseases such as cancer.
Another notable patent involves engineered nucleases designed for the treatment of hemophilia A. This invention encompasses engineered nucleases that can recognize and cleave a specific sequence within the Factor VIII gene. Beard's work in this area includes methods for creating genetically-modified cells and pharmaceutical compositions that utilize these engineered nucleases for therapeutic purposes.
Career Highlights
Clayton Beard is currently employed at Precision Biosciences, Inc., where he continues to innovate in the field of genetic engineering. His work has been instrumental in advancing the understanding and application of genetic modifications for medical treatments.
Collaborations
Beard collaborates with notable colleagues, including Derek Jantz and James Jefferson Smith, who contribute to his research and development efforts in genetic engineering.
Conclusion
Clayton Beard's innovative work in genetic engineering, particularly in the development of genetically-modified T cells and engineered nucleases, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases, including cancer and hemophilia A.